A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/506 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2720133
The present invention relates to a method for alleviation, prevention, and treatment of attention deficit disorder, sexual dysfunction, and related conditions by administering certain bioactive metabolites of the known anti-depressant compound gepirone. In a preferred embodiment, the compound is 4,4,-dimethyl-3-hydroxy-1- [4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,6- piperidinedione (3-OH gepirone).
La présente invention concerne un procédé pour le soulagement, la prévention et le traitement du trouble déficitaire de lattention, de dysfonctionnement sexuel et détats associés par ladministration de certains métabolites bioactifs du composé antidépresseur connu sous le nom de gépirone. Dans un mode de réalisation préféré, le composé est la 4,4,-diméthyl-3-hydroxy-1-[4-[4-(2-pyrimidinyl)-1-pipérazinyl]butyl]-2,6-pipéridinedione (3-OH gépirone).
Fabre Louis F.
Kramer Stephen J.
Fabre-Kramer Pharmaceuticals Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
3-hydroxy gepirone for the treatment of attention deficit... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-hydroxy gepirone for the treatment of attention deficit..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-hydroxy gepirone for the treatment of attention deficit... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2065319